1383995-99-0Relevant academic research and scientific papers
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
Dechristopher, Brian A.,Loy, Brian A.,Schrier, Adam J.,Wender, Paul A.,Marsden, Matthew D.,Zack, Jerome A.
, p. 705 - 710,6 (2020/09/02)
Bryostatin is a unique lead in the development of potentially transformative therapies for cancer, Alzheimer's disease and the eradication of HIV/AIDS. However, the clinical use of bryostatin has been hampered by its limited supply, difficulties in access
